| Serial Number | 79429785 |
| Word Mark | AELIS FARMA |
| Filing Date | Thursday, February 6, 2025 |
| Status | 680 - APPROVED FOR PUBLICATION |
| Status Date | Wednesday, July 15, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Licensing services regarding intellectual property rights in the pharmaceutical, medical, pharmacological, biological, biotechnological, biochemical, molecular and clinical fields; intellectual property licensing services for research and development in pharmaceutical, medical, pharmacological, biological, biotechnological, biochemical, molecular and clinical fields |
| Goods and Services | Evaluations and assessments of the goods of others in the scientific, pharmaceutical, pharmacological, biological, biotechnological, biochemical and clinical fields to assure compliance with industry standards, therapeutic efficiency, and patient tolerability; research and development in the pharmaceutical, medical, pharmacological, biological, biotechnological, biochemical and clinical fields; pre-clinical and clinical research in the field of neurology, psychiatry, dermatology, addictology, and pathology; pre-clinical and clinical research in the field of behavioral disorder treatment, cognitive disorder treatment, and metabolic syndrome treatment; preclinical and clinical research in the field of endocannabinoid system-dependent diseases; conducting clinical trials for others related to pharmaceuticals; scientific research for medical purposes in the field of neurology, psychiatry, dermatology, addictology, and pathology; scientific research for medical purposes in the field of behavioral disorder treatment, cognitive disorder treatment, and metabolic syndrome treatment; scientific research for medical purposes in the field of endocannabinoid system-dependent diseases; design, testing and development of molecules and new molecular entities for therapeutic purposes; scientific laboratory services; chemical and biochemical analyses; providing scientific analyses related to pharmaceutical and medicated preparation design; testing of new pharmaceutical products for third parties; provision of information related to scientific research in pharmaceutical, medical, pharmacological, biological, biotechnological, biochemical and clinical fields; providing and making available scientific information to third parties in the field of clinical and pre-clinical trials; providing information to third parties concerning results of clinical trials for medical and pharmaceutical products |
| NOT AVAILABLE | FARMA. |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Saturday, September 13, 2025 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 045 - Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Saturday, September 13, 2025 |
| Primary Code | 045 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | AELIS FARMA |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | FR |
| Event Date | Event Description |
| Thursday, August 7, 2025 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Saturday, September 13, 2025 | LIMITATION FROM ORIGINAL APPLICATION ENTERED |
| Thursday, January 29, 2026 | NEW REPRESENTATIVE AT IB RECEIVED |
| Thursday, January 29, 2026 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, January 29, 2026 | APPLICATION FILING RECEIPT MAILED |
| Friday, January 30, 2026 | ASSIGNED TO EXAMINER |
| Friday, January 30, 2026 | NON-FINAL ACTION WRITTEN |
| Saturday, January 31, 2026 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Friday, February 27, 2026 | REFUSAL PROCESSED BY MPU |
| Friday, February 27, 2026 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Thursday, March 19, 2026 | REFUSAL PROCESSED BY IB |
| Wednesday, July 15, 2026 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, July 15, 2026 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, July 15, 2026 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, July 15, 2026 | APPROVED FOR PUB - PRINCIPAL REGISTER |